Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Shinpei Morimoto, n/a

Nagasaki University, Japan

Disclosure(s): No financial relationships to disclose

Poster(s):

1128 - Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET